211 related articles for article (PubMed ID: 22777296)
1. Response to growth hormone therapy in children with Noonan syndrome: correlation with or without PTPN11 gene mutation.
Choi JH; Lee BH; Jung CW; Kim YM; Jin HY; Kim JM; Kim GH; Hwang JS; Yang SW; Lee J; Yoo HW
Horm Res Paediatr; 2012; 77(6):388-93. PubMed ID: 22777296
[TBL] [Abstract][Full Text] [Related]
2. Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11.
Noordam C; Peer PG; Francois I; De Schepper J; van den Burgt I; Otten BJ
Eur J Endocrinol; 2008 Sep; 159(3):203-8. PubMed ID: 18562489
[TBL] [Abstract][Full Text] [Related]
3. PTPN11 (protein tyrosine phosphatase, nonreceptor type 11) mutations and response to growth hormone therapy in children with Noonan syndrome.
Ferreira LV; Souza SA; Arnhold IJ; Mendonca BB; Jorge AA
J Clin Endocrinol Metab; 2005 Sep; 90(9):5156-60. PubMed ID: 15956085
[TBL] [Abstract][Full Text] [Related]
4. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome.
Binder G; Neuer K; Ranke MB; Wittekindt NE
J Clin Endocrinol Metab; 2005 Sep; 90(9):5377-81. PubMed ID: 15985475
[TBL] [Abstract][Full Text] [Related]
5. Response to growth hormone in short children with Noonan syndrome: correlation to genotype.
Binder G
Horm Res; 2009 Dec; 72 Suppl 2():52-6. PubMed ID: 20029239
[TBL] [Abstract][Full Text] [Related]
6. Impact of Growth Hormone Therapy on Adult Height in Patients with PTPN11 Mutations Related to Noonan Syndrome.
Malaquias AC; Noronha RM; Souza TTO; Homma TK; Funari MFA; Yamamoto GL; Silva FV; Moraes MB; Honjo RS; Kim CA; Nesi-França S; Carvalho JAR; Quedas EPS; Bertola DR; Jorge AAL
Horm Res Paediatr; 2019; 91(4):252-261. PubMed ID: 31132774
[TBL] [Abstract][Full Text] [Related]
7. Five-year response to growth hormone in children with Noonan syndrome and growth hormone deficiency.
Zavras N; Meazza C; Pilotta A; Gertosio C; Pagani S; Tinelli C; Bozzola M
Ital J Pediatr; 2015 Oct; 41():71. PubMed ID: 26444854
[TBL] [Abstract][Full Text] [Related]
8. [Phenotype variability in Noonan syndrome patients with and without PTPN11 mutation].
Ferreira LV; Souza SA; Montenegro LR; Arnhold IJ; Pasqualini T; Heinrich JJ; Keselman AC; Mendonça BB; Jorge AA
Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):450-6. PubMed ID: 17546245
[TBL] [Abstract][Full Text] [Related]
9. Noonan syndrome: rhGH treatment and PTPN11 mutation.
Wu X; Wu J; Yuan Y; Yang L; Yu L
Mol Genet Genomic Med; 2023 Nov; 11(11):e2266. PubMed ID: 37525886
[TBL] [Abstract][Full Text] [Related]
10. GH therapy in Noonan syndrome: Review of final height data.
Dahlgren J
Horm Res; 2009 Dec; 72 Suppl 2():46-8. PubMed ID: 20029237
[TBL] [Abstract][Full Text] [Related]
11. Noonan syndrome: growth to growth hormone - the experience of observational studies.
Ranke MB
Horm Res; 2009 Dec; 72 Suppl 2():36-40. PubMed ID: 20029235
[TBL] [Abstract][Full Text] [Related]
12. The short-term effects of growth hormone therapy on height velocity and cardiac ventricular wall thickness in children with Noonan's syndrome.
Cotterill AM; McKenna WJ; Brady AF; Sharland M; Elsawi M; Yamada M; Camacho-Hübner C; Kelnar CJ; Dunger DB; Patton MA; Savage MO
J Clin Endocrinol Metab; 1996 Jun; 81(6):2291-7. PubMed ID: 8964866
[TBL] [Abstract][Full Text] [Related]
13. Noonan syndrome: relationships between genotype, growth, and growth factors.
Limal JM; Parfait B; Cabrol S; Bonnet D; Leheup B; Lyonnet S; Vidaud M; Le Bouc Y
J Clin Endocrinol Metab; 2006 Jan; 91(1):300-6. PubMed ID: 16263833
[TBL] [Abstract][Full Text] [Related]
14. Growth response, near-adult height, and patterns of growth and puberty in patients with noonan syndrome treated with growth hormone.
Romano AA; Dana K; Bakker B; Davis DA; Hunold JJ; Jacobs J; Lippe B
J Clin Endocrinol Metab; 2009 Jul; 94(7):2338-44. PubMed ID: 19401366
[TBL] [Abstract][Full Text] [Related]
15. Abnormal growth in noonan syndrome: genetic and endocrine features and optimal treatment.
Padidela R; Camacho-Hübner C; Attie KM; Savage MO
Horm Res; 2008; 70(3):129-36. PubMed ID: 18663312
[TBL] [Abstract][Full Text] [Related]
16. IGF-I generation test in prepubertal children with Noonan syndrome due to mutations in the PTPN11 gene.
Bertelloni S; Baroncelli GI; Dati E; Ghione S; Baldinotti F; Toschi B; Simi P
Hormones (Athens); 2013; 12(1):86-92. PubMed ID: 23624134
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the PTPN11 gene in idiopathic short stature children and Noonan syndrome patients.
Ferreira LV; Souza SC; Montenegro LR; Malaquias AC; Arnhold IJ; Mendonca BB; Jorge AA
Clin Endocrinol (Oxf); 2008 Sep; 69(3):426-31. PubMed ID: 18331608
[TBL] [Abstract][Full Text] [Related]
18. PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes.
Brasil AS; Pereira AC; Wanderley LT; Kim CA; Malaquias AC; Jorge AA; Krieger JE; Bertola DR
Genet Test Mol Biomarkers; 2010 Jun; 14(3):425-32. PubMed ID: 20578946
[TBL] [Abstract][Full Text] [Related]
19. Abnormal growth in noonan syndrome: the challenge of optimal therapy.
Savage MO; Padidela R; Kirk JM; Malaquias AC; Jorge AA
Pediatr Endocrinol Rev; 2009 Jun; 6 Suppl 4():523-8. PubMed ID: 19550387
[TBL] [Abstract][Full Text] [Related]
20. [Noonan syndrome: from phenotype to growth hormone therapy].
Malaquias AC; Ferreira LV; Souza SC; Arnhold IJ; Mendonça BB; Jorge AA
Arq Bras Endocrinol Metabol; 2008 Jul; 52(5):800-8. PubMed ID: 18797587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
